Clinical Trial

Translocator Protein PET/CT in Various TSPO-Related Disease

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the potential usefulness of 18F-DPA714/FDPA positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various TSPO-related disease patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-05; most recent amendment 2025-02-07.
Trial Details
NCT Number NCT06725719
Lead Sponsor Tianjin Medical University
Collaborators: Tianjin Medical University General Hospital
Conditions Neuroinflammation, Stroke, Neurodegenerative Diseases
Enrollment 200 participants
Start Date 2018-11-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-11